News

Categories
  1. Ingestible 'bacteria on a chip' could help diagnose disease

    Researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding. 

    Industry News 

    Read more »
  2. New study shows promise of permethrin-treated clothing

    The Entomological Society of America reports today that a new study from the CDC (Centre for Disease Control) in the USA shows that permethrin-treated clothing may stop ticks from biting. This will thus reduce transmission of diseases like Lyme disease. Lab tests showed germ-carrying ticks can't move properly after contact with treated garments, making them sluggish and likely interfering with their ability to bite. 

    Industry News

     

    Read more »
  3. Lower prices negotiated for 9 medicines

    Service Announcement for price changes to 12 medicines. For 9 medicines we have negotiated lower prices for patients, 3 medicines have increases. 

    TheSocialMedwork service online 

    Read more »
  4. Preapproval vs unapproved or elsewhere approved medicines

    ‘Unapproved medicines’, ‘compassionate use’, ‘early access drugs’..

    preapproval vs unapproved

    Read more »
  5. Ovarian cancer

    A personalised vaccine which boosts a patient’s own immune system has nearly doubled the number of women surviving ovarian cancer by two years.

    ovarian cancer

    Read more »
  6. Lung cancer

    Following an earlier negative decision, NICE is now recommending NHS use of Roche’s immunotherapy Tecentriq for lung cancer.

    lung cancer

    Read more »
  7. Ovarian cancer

    Rubraca (rucaparib), already approved as a treatment for BRCA positive ovarian cancer, has been approved as a maintenance therapy for ovarian cancer regardless of BRCA mutation. 
    Industry news

    Read more »
  8. Leukemia

    The FDA approves Blincyto (blinatumomab) for patients with B-cell ALL, who are in remission but still have minimal residual disease.
    leukemia

    Read more »
  9. Pediatric leukemia

    FDA approves Tasigna (nilotinib) for certain pediatric patients with Ph+ CML in chronic phase.
    Industry news

    Read more »
  10. Diabetic retinopathy

    FDA approves Genentech’s Lucentis (ranibizumab injection) syringe for diabetic macular edema and diabetic retinopathy.

    FDA

    Read more »
  11. Leukemia

    CLL expert explains latest treatment developments in the field.
    leukemia

    Read more »
  12. Lymphoma

    FDA expands approval of Adcetris (brentuximab vedotin) for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.
    Industry news

    Read more »
  13. Prostate cancer

    Expert emphasises healthy lifestyle in prostate cancer care.
    Industry news

    Read more »
  14. HIV/AIDS

    The FDA has approved a new HIV treatment for patients with limited treatment options.
    HIV AIDS

    Read more »
  15. Leukemia

    Kymriah, the first FDA-approved CAR-T cell therapy, is showing promising results in treating children with acute lymphoblastic leukemia.
    leukemia

    Read more »
  16. Breast cancer

    The Food and Drug Administration (FDA) have extended the approval of Verzenio (abemaciclib) to now be a first line treatment for some types of advanced or metastatic breast cancer.
    breast cancer

    Read more »
  17. Thyroid cancer

    The UK institute NICE gives 3 nods in thyroid cancer: Cometriq (cabozantinib), Nexavar (sorafenib) and Lenvima (lenvatinib).
    thyroid cancer

    Read more »
  18. Parkinson’s disease

    FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions. 
    parkinson's disease

    Read more »
  19. Lung cancer

    Imfinzi (durvalumab), already approved for some bladder cancers, is now FDA approved for some patients with lung cancer.
    Industry news

    Read more »
  20. New prices negotiated! Reductions for 38 products

    Price decreases for 38 medicines

    Read more »
  21. Leukemia

    In a recent trial, 80% of patients with (MRD)-positive acute lymphoblastic leukemia (ALL) who were treated with a drug called Blincyto (blinatumomab) achieved a complete response.
    Industry news

    Read more »
  22. Prostate cancer

    The FDA has approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread, but that continues to grow despite treatment with hormone therapy.
    Industry news

    Read more »
  23. MS

    The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
    Industry news

    Read more »
  24. Oncology

    Scientists experimenting with an innovative treatment for cancer have now devised a targeted injection that has already successfully eliminated tumours in mice.
    Industry news

    Read more »
  25. Immunotherapy

    The first ever patient to be treated with a new type of CAR-T cell therapy in a novel clinical trial is now in remission.
    Industry news

    Read more »
  26. New microneedle product could help people with ALS, MS and diabetes

    Remember the hypospray from Star Trek? Maybe it's close to reality.

    Star Trek magazine cover

    Read more »
  27. Breast cancer

    A new combination of medicines is showing positive results in ER/HER2-Positive breast cancer.
    Industry news

    Read more »
  28. Autism

    The experimental drug from Roche (balovaptan) has now been given Breakthrough Therapy Designation, potentially placing the drug on a faster path to market as the first pharmacological treatment for autism spectrum disorder (ASD). Pharmatimes, 30/01/2018.
    Industry news

    Read more »
  29. Digestive tract cancer

    Following the EMA’s approval in late 2017, the FDA has now also approved Lutathera (lutetium Lu 177 dotatate) for certain digestive tract cancers.
    Industry news

    Read more »
  30. What are the latest breakthroughs in multiple sclerosis (MS)?

    The potential of neuroprotective agents for a whole new form of treatment.

    MS

    Read more »
US 0